Goldman Sachs Group Inc Dynavax Technologies Corp Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Goldman Sachs Group Inc holds 4,291,828 shares of DVAX stock, worth $54.6 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,291,828

Previous 4,753,388 9.71%

Holding current value

$54.6 Million

Previous $53.4 Million 10.43%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.05 - $11.61 $4.64 Million - $5.36 Million	-461,560 Reduced 9.71%	4,291,828 $47.8 Million
Q2 2024 Aug 13, 2024	BUY	$10.73 - $12.58 $6.24 Million - $7.32 Million	581,969 Added 13.95%	4,753,388 $53.4 Million
Q1 2024 May 15, 2024	BUY	$11.7 - $14.98 $6.72 Million - $8.6 Million	574,280 Added 15.96%	4,171,419 $51.8 Million
Q4 2023 Feb 13, 2024	BUY	$13.09 - $14.98 $8.44 Million - $9.65 Million	644,428 Added 21.82%	3,597,139 $50.3 Million
Q3 2023 May 14, 2024	SELL	$12.64 - $14.99 $8.15 Million - $9.66 Million	-644,428 Reduced 17.92%	2,952,711 $43.6 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $14.99 $8.08 Million - $9.59 Million	-639,556 Reduced 17.8%	2,952,711 $43.6 Million
Q2 2023 May 14, 2024	SELL	$9.85 - $13.17 $1.04 Million - $1.4 Million	-105,985 Reduced 2.87%	3,592,267 $46.4 Million
Q2 2023 Aug 14, 2023	SELL	$9.85 - $13.17 $1.04 Million - $1.4 Million	-105,985 Reduced 2.87%	3,592,267 $46.4 Million
Q1 2023 May 14, 2024	BUY	$9.44 - $11.88 $19.9 Million - $25 Million	2,107,157 Added 132.43%	3,698,252 $36.3 Million
Q1 2023 May 11, 2023	BUY	$9.44 - $11.88 $19.9 Million - $25 Million	2,107,157 Added 132.43%	3,698,252 $36.3 Million
Q4 2022 May 14, 2024	BUY	$10.27 - $13.29 $2.22 Million - $2.87 Million	216,009 Added 15.71%	1,591,095 $16.9 Million
Q4 2022 Feb 13, 2023	BUY	$10.27 - $13.29 $2.22 Million - $2.87 Million	216,009 Added 15.71%	1,591,095 $16.9 Million
Q3 2022 May 14, 2024	SELL	$9.93 - $17.44 $3.64 Million - $6.39 Million	-366,139 Reduced 21.03%	1,375,086 $14.4 Million
Q3 2022 Nov 10, 2022	SELL	$9.93 - $17.44 $3.64 Million - $6.39 Million	-366,139 Reduced 21.03%	1,375,086 $14.4 Million
Q2 2022 May 14, 2024	SELL	$7.45 - $12.83 $13.8 Million - $23.8 Million	-1,855,914 Reduced 51.59%	1,741,225 $21.9 Million
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $3.27 Million - $5.64 Million	-439,503 Reduced 20.15%	1,741,225 $21.9 Million
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $3.34 Million - $4.94 Million	342,361 Added 18.62%	2,180,728 $23.6 Million
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $9.85 Million - $15.7 Million	747,533 Added 68.53%	1,838,367 $25.9 Million
Q3 2021 Nov 10, 2021	BUY	$9.16 - $19.83 $9.99 Million - $21.6 Million	1,090,834 New	1,090,834 $21 Million

Others Institutions Holding DVAX

# of Institutions

275

Shares Held

130M

Call Options Held

451K

Put Options Held

203K

View Full List

About DYNAVAX TECHNOLOGIES CORP

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.61B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

More about DVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Dynavax Technologies Corp Transaction History